Description

Letrozol Coated Tablets 2.5 mg. №100

Ingredients

Each coated tablet contains 2.5 mg of Letrozole as the active ingredient.

Dosage

The recommended dosage of Letrozol is 2.5 mg once daily, with or without food.

Indications

Letrozol is indicated for the treatment of hormone receptor-positive breast cancer in postmenopausal women.

Contraindications

Do not use Letrozol if you are pregnant, as it may cause harm to the unborn baby.

Directions

Take Letrozol exactly as prescribed by your healthcare provider. Do not take more or less than the recommended dose.

Scientific Evidence

Letrozole, the active ingredient in Letrozol tablets, is an aromatase inhibitor that works by reducing the production of estrogen in the body. This mechanism of action has been shown to be effective in the treatment of hormone receptor-positive breast cancer. Clinical trials have demonstrated the efficacy of Letrozole in improving disease-free survival and reducing the risk of cancer recurrence compared to other treatment options.

Research published in the New England Journal of Medicine has highlighted the benefits of Letrozole in the adjuvant treatment of early-stage breast cancer. The study showed a significant improvement in disease-free survival rates in postmenopausal women with hormone receptor-positive breast cancer who received Letrozole compared to tamoxifen.

Additional Information

It is important to discuss with your healthcare provider about any other medications you are taking before starting Letrozol therapy, as drug interactions may occur. Letrozol may cause side effects such as hot flashes, fatigue, and joint pain. If you experience any severe side effects, contact your doctor immediately.

Always follow the prescribed dosage and do not discontinue the medication without consulting your healthcare provider. Letrozol coated tablets should be stored at room temperature away from moisture and heat.